1. Home
  2. EMF vs STXS Comparison

EMF vs STXS Comparison

Compare EMF & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Templeton Emerging Markets Fund

EMF

Templeton Emerging Markets Fund

HOLD

Current Price

$17.57

Market Cap

254.5M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$2.37

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMF
STXS
Founded
1987
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.5M
210.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
EMF
STXS
Price
$17.57
$2.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
29.3K
471.8K
Earning Date
01-01-0001
11-11-2025
Dividend Yield
6.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,075,000.00
Revenue This Year
N/A
$24.48
Revenue Next Year
N/A
$29.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.62
52 Week Low
$10.58
$1.54
52 Week High
$12.67
$3.59

Technical Indicators

Market Signals
Indicator
EMF
STXS
Relative Strength Index (RSI) 61.08 44.44
Support Level $17.43 $2.34
Resistance Level $17.78 $2.44
Average True Range (ATR) 0.22 0.10
MACD 0.08 0.03
Stochastic Oscillator 82.44 55.17

Price Performance

Historical Comparison
EMF
STXS

About EMF Templeton Emerging Markets Fund

Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: